Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - EPS
EPS UTHR - United Therapeutics Corporation
21
LAST VALUE
40.89%
2 YEAR CAGR
9.22%
5 YEAR CAGR
19.68%
10 YEAR CAGR